C Dickson1, M T Pham2, V Nguyen2, C Brubacher2, M S Silverman3, K Khaled2, G Hovhannisyan2. 1. Canadian Field Epidemiology Program, Public Health Agency of Canada, Ottawa, ON. 2. Middlesex-London Health Unit, London, ON. 3. Division of Infectious Diseases, Schulich School of Medicine & Dentistry, Western University, London, ON.
Abstract
BACKGROUND: Outbreaks of invasive group A streptococcal infection (iGAS) have historically occurred in institutional settings. Increasingly, community-based outbreaks have been reported, often among marginalized populations, yet few guidelines exist for managing iGAS outbreaks in such settings. OBJECTIVE: To describe the ongoing outbreak of iGAS in Middlesex-London, Ontario, and the challenges that arose while applying current guidelines to a marginalized population in a community setting. METHODS: The outbreak investigation included all iGAS cases in Middlesex-London with an onset date from April 1, 2016 to February 28, 2018. Clinical specimens were submitted to provincial and federal laboratories for typing. Public health management of the outbreak involved environmental health inspections, contact tracing, chemoprophylaxis of close contacts, swabbing to determine colonization rates of Streptococcus pyogenes, and communicating with stakeholders and the public. RESULTS: A total of 156 confirmed cases of iGAS corresponding to 147 individuals were reported in less than two years. More than 60% of cases occurred in men (n=91) and almost half (n=71) of the total number of cases were persons who used drugs (PWUD) and/or were under-housed. Of the PWUD cases, 58 of 65 (89%) used injection drugs. Key challenges in controlling this outbreak included reaching PWUD and under-housed people; completing a case history and contact list; facilitating completion of treatment; dealing with concurrent infections such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV); and optimizing environmental health conditions. Guidelines were adapted so contacts who shared drugs or injection drug equipment with a known iGAS case would be offered chemoprophylaxis regardless of the clinical severity of the case. To optimize treatment completion, a single-dose of azithromycin for individuals in close contact with PWUD and/or under-housed cases was given. Cases with macrolide-resistant strain emm9 have recently emerged. CONCLUSION: The application of institution-based guidelines for iGAS outbreaks has been ineffective in controlling this particular community outbreak. There is a need for guidelines on managing outbreaks of iGAS in the community especially when an outbreak involves marginalized populations.
BACKGROUND: Outbreaks of invasive group A streptococcal infection (iGAS) have historically occurred in institutional settings. Increasingly, community-based outbreaks have been reported, often among marginalized populations, yet few guidelines exist for managing iGAS outbreaks in such settings. OBJECTIVE: To describe the ongoing outbreak of iGAS in Middlesex-London, Ontario, and the challenges that arose while applying current guidelines to a marginalized population in a community setting. METHODS: The outbreak investigation included all iGAS cases in Middlesex-London with an onset date from April 1, 2016 to February 28, 2018. Clinical specimens were submitted to provincial and federal laboratories for typing. Public health management of the outbreak involved environmental health inspections, contact tracing, chemoprophylaxis of close contacts, swabbing to determine colonization rates of Streptococcus pyogenes, and communicating with stakeholders and the public. RESULTS: A total of 156 confirmed cases of iGAS corresponding to 147 individuals were reported in less than two years. More than 60% of cases occurred in men (n=91) and almost half (n=71) of the total number of cases were persons who used drugs (PWUD) and/or were under-housed. Of the PWUD cases, 58 of 65 (89%) used injection drugs. Key challenges in controlling this outbreak included reaching PWUD and under-housed people; completing a case history and contact list; facilitating completion of treatment; dealing with concurrent infections such as human immunodeficiency virus (HIV) and hepatitis C virus (HCV); and optimizing environmental health conditions. Guidelines were adapted so contacts who shared drugs or injection drug equipment with a known iGAS case would be offered chemoprophylaxis regardless of the clinical severity of the case. To optimize treatment completion, a single-dose of azithromycin for individuals in close contact with PWUD and/or under-housed cases was given. Cases with macrolide-resistant strain emm9 have recently emerged. CONCLUSION: The application of institution-based guidelines for iGAS outbreaks has been ineffective in controlling this particular community outbreak. There is a need for guidelines on managing outbreaks of iGAS in the community especially when an outbreak involves marginalized populations.
Entities:
Keywords:
community; invasive group A streptococcus; marginalized population; outbreak; persons who use drugs
Authors: B Schwartz; J A Elliott; J C Butler; P A Simon; B L Jameson; G E Welch; R R Facklam Journal: Clin Infect Dis Date: 1992-08 Impact factor: 9.079
Authors: Sandra J Valenciano; Jennifer Onukwube; Michael W Spiller; Ann Thomas; Kathryn Como-Sabetti; William Schaffner; Monica Farley; Susan Petit; James P Watt; Nancy Spina; Lee H Harrison; Nisha B Alden; Salina Torres; Melissa L Arvay; Bernard Beall; Chris A Van Beneden Journal: Clin Infect Dis Date: 2021-12-06 Impact factor: 9.079
Authors: Barbara Strauss; Martin Tepper; Diane Lu; François Gagnon; Eric Girard; Walter Demczuk; Irene Martin; Martine Massé; Kirsten Barnes Journal: Can Commun Dis Rep Date: 2020-09-03
Authors: Katherine J Kasper; Iswarya Manoharan; Brian Hallam; Charlotte E Coleman; Sharon L Koivu; Matthew A Weir; John K McCormick; Michael S Silverman Journal: PLoS One Date: 2019-08-09 Impact factor: 3.240